Gut Microbiome Interactions in Primary Sclerosing Cholangitis
Dátum
Authors
Folyóirat címe
Folyóirat ISSN
Kötet címe (évfolyam száma)
Kiadó
DOI
Absztrakt
Primary sclerosing cholangitis (PSC) is a rare, progressive immune-mediated cholangiopathy with substantial risks of liver failure, colorectal neoplasia, and cholangiocarcinoma. This thesis examines evidence that genetic susceptibility, intestinal dysbiosis, barrier dysfunction, immune activation, and altered bile-acid signalling interact within a self-reinforcing gut-liver axis. PSC-associated dysbiosis is characterized by reduced microbial diversity, enrichment of pathobionts, depletion of SCFA-producing bacteria, and altered microbial metabolic functions. Impaired intestinal-barrier integrity may permit microbial products to reach the liver and activate inflammatory pathways in immune cells and cholangiocytes, promoting periductal fibrosis. Microbiome- and bile-acid-directed treatments have shown preliminary benefits, but none has demonstrated sustained improvement in transplant-free survival or disease prevention. Future progress requires longitudinal multiomic studies and rigorous clinical trials using appropriately stratified patients and clinically meaningful endpoints.